INTRODUCTION
Many phytopathogenic bacteria and fungi secrete toxins with phytotoxic activity and a broad spectrum of antimicrobial properties (Guenzi et al., 1998) . Albicidin phytotoxins produced by Xanthomonas albilineans are key pathogenicity factors in the development of leaf scald, one of the most devastating diseases of sugarcane (Saccharum interspecific hybrids) (Ricaud & Ryan, 1989 ; Zhang et al., 1999) . Albicidins selectively block prokaryote DNA replication and cause the characteristic chlorotic symptoms of leaf scald disease by blocking chloroplast development (Birch & Patil, 1983 , 1985b , 1987a . Because albicidins are rapidly bactericidal at nanomolar concentrations against a broad range of Gram-positive and Gram-negative bacteria, they are 
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also of interest as potential clinical antibiotics (Birch & Patil, 1985a) .
The major antimicrobial component of the family of albicidins produced in culture by X. albilineans has been partially characterized as a low-M r compound with several aromatic rings (Birch & Patil, 1985a) . Low yields have slowed studies into the chemical structure of albicidin, its application as a tool to study prokaryote DNA replication and its development as a clinical antibiotic (Zhang et al., 1998) . Genetic analysis of albicidin biosynthesis is likely to indicate approaches to increase yields, probable structural features, and opportunities for engineering novel antibiotics in this family.
Transposon mutagenesis revealed that at least two gene clusters spanning more than 60 kb in the genome of X. albilineans are involved in albicidin production (Rott et al., 1996 ; Wall & Birch, 1997) . Recently, a gene (xabA) required for albicidin biosynthesis in X. albilineans has been identified and found to encode a phosphopantetheinyl transferase, which may activate albicidin synthetases in the albicidin biosynthetic pathway (Huang et al., 2000b) . Here, we show that a second gene (xabB) required for albicidin biosynthesis encodes a Albicidin multifunctional synthetase gene large, multifunctional enzyme, with unusual polyketide synthase (PKS) modules fused to a non-ribosomal peptide synthetase (NRPS).
METHODS
Bacterial strains and plasmids. The properties of bacteria and plasmids used are listed in Table 1 .
Media, culture conditions and antibiotics. X. albilineans strains were routinely cultured on sucrose peptone (SP) medium at 28 mC (Birch & Patil, 1985b) . Escherichia coli strains were used as hosts in cloning experiments and were grown on LB medium at 37 mC (Sambrook et al., 1989) . Broth cultures were aerated by shaking at 200 r.p.m. on an orbital shaker. Modified YEB medium (Van Larebeke et al., 1977) was used for patch mating. The following antibiotics were added to media as required : kanamycin, 50 µg ml − " ; tetracycline, 15 µg ml − " ; ampicillin, 100 µg ml − " ; and spectinomycin, 50 µg ml − ".
Routine genetic procedures. Bacterial genomic and plasmid DNA isolation, gel electrophoresis, DNA restriction digests, ligation reactions, transformation and colony hybridization were performed by routine procedures (Sambrook et al., 1989) . DNA fragments were excised from agarose gels and residual agarose was removed with the BRESAclean DNA purification kit (GeneWorks).
Construction of a X. albilineans partial genomic library.
Genomic DNA from X. albilineans Xa13 was digested with EcoRI and size-fractionated. DNA fragments of 15-20 kb were ligated to dephosphorylated EcoRI-cleaved pBluescript II SK. The ligated DNA was electroporated into E. coli TOP10. Transformants were selected on LB agar medium containing ampicillin, and stored in LB broth with 15 % glycerol at k70 mC.
DNA sequencing and analysis. Sequencing reactions were performed by dideoxynucleotide chain termination (Sanger et al., 1977) using a BigDye Terminator Cycle Sequencing kit and a 373A DNA sequencer (PE Applied Biosystems) through the Australian Genome Research Facility. Oligonucleotide primers were purchased from GeneWorks. Analyses of DNA and protein sequences in the GenBank, EMBL, PIR and SWISS-PROT databases were carried out by using the University of Wisconsin Genetics Computer Group (UWGCG) programs , ,  and  through WebANGIS version 2.0.
PCR amplification. BamHI-digested genomic DNA from X. albilineans LS157 was religated at low concentration (0n5 µg ml − ") to generate circular DNA molecules as templates for inverse PCR. Three primers, one from the IS terminal region of Tn5 (IR2 : 5h-CGGGATCCTCACATGGAAGTC-AGATCCTG-3h), and two flanking the unique BamHI restriction site of Tn5 (BL : 5h-GGGGACCTTGCACAGAT-AGC-3h and BR : 5h-CATTCCTGTAGCGGATGGAGATC3h), were used to amplify the sequences flanking the Tn5 insertion in the genome of LS157. The amplified fragments (1n4 kb and 6n0 kb) were cloned into pZErO-2, yielding pZIL and pZIR (Fig. 1) .
PCR was performed in a volume of 50 µl with 200 ng genomic DNA (or 10 ng plasmid DNA), 0n4 ng of each primer µl − ", 0n2 mM of each dNTP, 1n8 mM Mg# + and 1 unit of elongase enzyme mix (Life Technologies). A 10 min initial denaturation step at 94 mC was followed by 35 thermal cycles of denaturation at 94 mC for 1 min, annealing at 55 mC for 1 min, and extension at 72 mC for 1 min per 1 kb of expected amplification.
Construction of promoter probes and glucuronidase assay.
Plasmid pRG960sd contains a promoterless β-glucuronidase gene (uidA) downstream of a multiple cloning site ( Van den Edde et al., 1992) . Sequence upstream of xabB (nucleotide residues 1005-1210 or 521-1210) was amplified from pXABB by PCR. Forward primer P1F1 (5h-ACGCGGATCCCAGC-AGGGTGTCATACACG-3h) or P1F2 (5h-TCGCGGATCCG-CGCGATTGAAGTAGTCC-3h) contained a BamHI restriction site (underlined). Reverse primer P1R (5h-TCCCCCGGG CGGCCAGCGTGGTGCTACTAC-3h) introduced a XmaI restriction site (underlined). PCR fragments were ligated into BamHI\XmaI-cut pRG960sd, yielding pRG960p1 and pRG960p2. These constructs were mobilized from E. coli DH5α into X. albilineans LS155 as described below.
Promoter strength was quantified by fluorometric analysis of glucuronidase (GUS) activity (Jefferson, 1987 ; Xiao et al., 1992) . The protein content in cell lysates was determined by the dye-binding method (Bradford, 1976 ) using a Bio-Rad protein assay kit.
Bacterial conjugation. DNA transfer between E. coli donor JM109(pLAFR3pinsert) or DH5α(pRG960sdpinsert) and X. albilineans recipient (LS157, LS-JP2 or LS155), was accomplished by triparental transconjugation with helper strain pRK2013. Mid-exponential-phase cultures of the recipient were spotted onto agar plates containing YEB medium with no antibiotics (20 µl per spot). After the liquid had been absorbed by the agar, 20 µl of mid-exponentialphase culture of the helper was added to each spot. The liquid was again allowed to absorb, and 20 µl of mid-exponentialphase culture of the donor was added to each spot. After incubation of the mating plates overnight at 28 mC, transconjugants were selected on SP plates supplemented with ampicillin, and tetracycline or spectinomycin.
Assay and quantification of albicidin production. Albicidin was quantified by a microbial plate bioassay as described previously (Birch & Patil, 1985b) , except that the 10 ml basal layer of LB agar and the 5 ml overlayer of 50 % LB with 1 % agar were supplemented with tetracycline or spectinomycin, and E. coli DH5α(pLAFR3) or DH5α(pRG960sd) was used as the indicator strain. This change avoided interference by tetracycline or spectinomycin, which were added to some cultures to ensure retention of pLAFR3 or pRG960sd derivatives in X. albilineans. Inhibition zone widths in the bioassay were converted to albicidin concentrations by interpolation on a dose-response plot produced under the same assay conditions. The plot fitted the formula log[Alb] l 0n3 W k0n92, where [Alb] is units of albicidin per 20 µl sample and W is the width in millimeters of the zone of growth inhibition surrounding each well.
RESULTS
Cloning and sequencing of xabB gene required for albicidin production X. albilineans Tox − mutant LS157 contains a single Tn5 insertion, in a 4n1 kb ClaI restriction fragment or in a 16n5 kb EcoRI restriction fragment ( library of wild-type X. albilineans Xa13, using probes described in the legend to Fig. 1(b) . Subclones pSEBL and pSEBR were derived from pXABB ( Fig. 1c ; Table  1 ). The double-strand sequence of the 16 511 bp EcoRI genomic fragment in pXABB was obtained by a primerwalking approach, using subclones pBC157, pZIL, pZIR, pSEBL and pSEBR. The Tn5 insertion in the genome of LS157 is accompanied by a 9 bp perfect repeat sequence (GTCCTGAAG), commencing at bp 2490 in the sequence deposited in GenBank with accession number AF239749. (Fig. 1) . The motifs characteristic of these domains are aligned with those from other organisms in Fig. 3 . The AL domain contains the conserved adenylation core sequence (SGSSG) and the ATPase motif (TGD), and shows 22-30 % identity and 50-60 % similarity to prokaryotic and eukaryotic aromatic-acid CoA ligases and long-chain fatty-acid CoA ligases (protein symbols and GenBank accession nos : MycA, AF184956 ; LCFA, P46450 ; PksJ, P40806 ; ComL2, P14913 ; FkbB, AF082099 ; RifA, X86780 ; RapA, AF040570). The three ACP domains show up to 39n2 % identity and 78n6 % similarity to ACPs (MycA, AF184956 ; HMWP1, Y12527 ; Ta1, AJ006977 ; PksX6, U11039 ; EryA1, M63676 ; MAS, M95808), and all contain a 4h-phosphopantetheinyl-binding cofactor box GxDS(I\L) (Hopwood & Sherman, 1990) , except that A replaces G in ACP1 (Fig. 3) . The two KS domains show up to 56n1 % identity and 80n8 % similarity to prokaryotic β-ketoacyl synthases (KSs) (MycA, AF184956 ; HMWP1, Y12527 ; Ta1, AJ006977 ; PksX6, U11039 ; PksM, O31781 ; EryA1, M63676 ; PpsA, G3261605). Both contain motif GPxxxxxxxCSxSL around the active site Cys, and two His residues downstream of the active site Cys, in motifs characteristic of these enzymes (Donadio et al., 1991 ; Hopwood, 1997 ; Huang et al., 1998) . The KR domain shows up to 27n9 % identity and 61n8 % similarity to other β-ketoacyl reductases (HMWP1, Y12527 ; Ta1, AJ006977 ; PksX6, U11039 ; EryA1, M63676 ; MAS, M95808), and contains the NAD(P)H-binding site GGxGxLG (Scrutton et al., 1990) .
At the C-terminus of XabB is an apparent peptide synthetase region linked to the PKS module via a peptidyl carrier protein (PCP) domain (Fig. 1) . The peptide synthetase region shows 31-38 % identity and 60-63 % similarity with members of the peptide synthetase family from Bacillus (TycB, AF004835 ; FenD, AJ011849 ; BacC, AF007865 ; GrsB, X61658 ; DhbF, AF047828 ; SrfAA, X70356), Streptomyces (SnbDE, Y11547), Pseudomonas (SyrE, AF047828) and E. coli (EntF, P11454). It displays the ordered condensation (C), adenylation (A) and PCP domains typical of such multienzymes , followed by an extra C domain. The conserved sequences, characteristic of the domains commonly found in peptide synthetases, are compared with those from XabB in Table 2 .
Complementation of xabB and xabC genes
Plasmids pLXABB1 and pLXABB2 contain the 16n5 kb EcoRI fragment from pXABB ( Fig. 1) , cloned into broad-host-range cosmid pLAFR3 in forward and reverse orientation to the lac promoter, respectively. Mobilization of pLAFR3, pLXABB1, pLXABB2 or pLXABC by bacterial conjugation into Tox − mutants LS157 (xabB ::Tn5) and LS-JP2 (xabC insertional mutant) occurred at a frequency of 1n5i10 −# transconjugants per recipient cell. Albicidin production was undetectable in the Tox − mutant LS157 and pLAFR3 controls. Introduction of the xabC gene on pLXABC restored albicidin production in LS-JP2, but not in LS157. Introduction of pLXABB1 or pLXABB2 expressing the full-length xabB and a truncated but functional xabC further enhanced albicidin production in LS-JP2 and in LS157 relative to the wild-type parental strain LS155 (Fig. 4) .
Functional analysis of xabB promoter region
GUS activity was undetectable in LS155 and LS155(pRG960sd) controls. Plasmid pRG960p1 or pRG960p2, with 206 bp or 690 bp from the xabB promoter region upstream of GUS, both conferred GUS activity with no difference in expression level or pattern in X. albilineans LS155 (Fig. 5) . GUS activity increased with culture density, whereas albicidin accumulation was delayed until late in the exponential-growth phase.
DISCUSSION
The xabB gene required for albicidin biosynthesis in X. albilineans encodes a large (526 kDa) protein with the sequence characteristics of a mixed-function PKS and NRPS. Tox − Tn5-insertional mutant LS157 was complemented in trans by a 16n5 kb EcoRI fragment including xabB (14n4 kb) and a truncated downstream xabC, but not by xabC alone. A 206 bp region upstream of the xabB start codon is a functional promoter during the phase of albicidin accumulation in X. albilineans (Fig. 5) . The xabB gene uses TTG as start codon, which may impose post-transcriptional control on the rate of gene product formation (McCarthy & Gualerzi, 1990) . We have shown elsewhere that the downstream cistron xabC encodes a methyltransferase (MT) involved in albicidin biosynthesis, and that no other downstream cistron in the operon is required for albicidin production (Huang et al., 2000a) . the growing polyketide chain (Cane et al., 1998 ; Keating & Walsh, 1999) . The catalytic domains are arranged in modules, punctuated by acyl carrier protein (ACP) domains that tether the nascent polyketide while it undergoes the catalytic modifications programmed in the associated module. For each polyketide there is an initiation module, a series of elongation modules that define the length and structure of the polyketide chain, and a termination module to release the product from the final tether. The initiation module typically comprises an acyltransferase (AT) domain that couples the initial acyl group from an acyl-CoA substrate to the phosphopantetheinyl tether of the first ACP domain. Each elongation module typically comprises at least a KS, AT and ACP. The AT selects and loads an acyl group (typically malonate) onto the ACP. The KS removes the growing polyketide unit from the upstream ACP and couples it by decarboxylation to this next tethered acyl group (typically extending the chain by one acetyl group). Other catalytic domains (e.g. KR, or dehydratase, DH) within an elongation module can modify the newly elongated polyketide before it is transferred to the next module. A thioesterase (TE) domain in the termination module accomplishes release of the assembled polyketide from the last ACP (Cane et al., 1998 ; Keating & Walsh, 1999) .
Biosynthesis of a polyketide can involve the sequential action of several PKS proteins, each with one to six elongation modules (MacNeil et al., 1992 ; Aparicio et al., 1996) . There are variations on the modular PKS design, including participation by some loading domains across modules or in trans from separate proteins (Keating & Walsh, 1999) , and several examples of hybrid PKS\NRPS proteins (Albertini et al., 1995 ; Gehring et al., 1998 ; Duitman et al., 1999 ; Paitan et al., 1999) . Subsequent modification of the polyketide by dedicated tailoring enzymes is generally required to complete the biologically active product (Cane et al., 1998) .
XabB commences with an AL domain (residues 1-629) followed by an ACP domain (ACP1, residues 630-731). In other PKS systems, an N-terminal AL is involved in activation and incorporation of 3,4-dihydroxycyclohexane carboxylic acid, 3-amino-5-hydroxybenzoic acid (AHBA) or a long-chain fatty acid as a starter (Duitman et al., 1999) ; (c) Y. pestis HMWP1 for yersiniabactin biosynthesis (Gehring et al., 1998) ; (d) M. xanthus partial gene product Ta1 for TA biosynthesis (Paitan et al., 1999) ; (e) B. subtilis PksX6 for unknown function (Albertini et al., 1995) . White boxes indicate PKS regions, black boxes indicate NRPS regions. Relative positions of deduced catalytic domains are indicated. Vertical bars follow the carrier domains at the end of each biosynthetic module.
( Aparicio et al., 1996 ; Motamedi & Shafiee, 1998 ; Tang et al., 1998 ; Duitman et al., 1999) . It may be possible to determine the substrate specificity of the AL domain by heterologous expression and purification of the module 1 protein containing AL plus ACP1 domains, and ATPpyrophosphate exchange assays of the purified fusion protein with potential substrates, as applied to NRPS internal A domains (Guenzi et al., 1998 ; Stachelhaus et al., 1998 Stachelhaus et al., , 1999 .
The second module in XabB contains a KS (residues 732-1165) and a KR (residues 1811-1971) upstream of two ACPs (residues 2457-2522 and 2544-2613), but lacks any discernable AT domain (Fig. 1) . Tandem ACPs are unusual within PKS modules. Other instances include WA for a green pigment formation and ST for sterigmatocystin biosynthesis in Aspergillus nidulans (Mayorga & Timberlake, 1992 ; Yu & Leonard, 1995) , the PKS1 product for melanin biosynthesis in Colletotrichum lagenarium (Takano et al., 1995) and the pksX7 product for an unknown polyketide in Bacillus subtilis (Albertini et al., 1995) . The significance of the tandem ACPs in these systems has not been resolved. ST performs the iterative addition of seven acetate units (from malonyl-CoA donors) to a hexanoate primer, to form an octaketide intermediate that is stabilized by cyclization, yielding a product with three aromatic rings (Yu & Leonard, 1995) . This is interesting in the context of the apparent aromatic structure of albicidin. Although most aromatic polyketides are synthesized by iterative type I or type II PKSs (Shen, 2000) , there is an example of synthesis by a non-iterative type I PKS in the case of pyoluteorin in Pseudomonas fluorescens (Nowak-Thompson et al., 1997) .
Possibilities in the case of XabB include use of either or both of ACP2 and ACP3 in chain elongation. One domain could be non-functional, as observed for modification domains in various PKSs (Aparicio et al., 1996 ; Nowak-Thompson et al., 1997 ; Tang et al., 1998) . Selection between ACP2 and ACP3 could depend on which has been loaded with an appropriate acyl group by a separate AT enzyme. If they have different loading specificities (e.g. for malonyl-CoA versus methylmalonyl-CoA), this could contribute to the production of multiple, structurally related albicidins by the same synthetase. The evidence that domains typically found within a module can in some instances act in trans (Keating & Walsh, 1999) , including a trans-acting KS in the deduced type I mycobactin PKS (Quadri et al., 1998) , supports the possibility that ACP2 and ACP3 could act sequentially in chain elongation. Finally, ACP2 and ACP3 could accomplish the iterative biosynthesis of a longer ketide chain if ACP3 serves as a waiting position allowing polymerization of successive products from ACP2, as for the tandem PCP domains in enniatin synthetase (Zocher & Keller, 1997) . As discussed below, it will be easier to distinguish between these possibilities when the complete structure of albicidin is elucidated.
The third module in XabB contains a KS (residues 2630-3046) followed by a PCP (residues 3221-3307) at the start of the NRPS region. Four other fused PKS\ NRPS systems (Albertini et al., 1995 ; Gehring et al., 1998 ; Duitman et al., 1999 ; Paitan et al., 1999) are known, three of which lack recognizable AT domains (Fig. 6) . Yersinia pestis HMWP1 contains a typical PKS elongation module (including AT) and an NRPS module with a terminating thioesterase (TE) domain. It is the third protein, following an AL (YbtE) and NRPS (HMWP2), in the biosynthetic apparatus for yersiniabactin (Gehring et al., 1998 (Duitman et al., 1999) and an AT gene located 20 kb upstream of ta1 (Paitan et al., 1999) . We have not yet identified an AT gene in the xab gene cluster.
From the characteristics of albicidin (Birch & Patil, 1985a) and the architecture of the XabB PKS region (Fig.  1) , it is likely that : (i) the AL couples CoA to an aryl or acyl residue in an ATP-dependent reaction and loads the activated residue onto the 4h-phosphopantetheine prosthetic arm of ACP1 ; (ii) an acyl group is loaded onto ACP2 or\and ACP3 by a separate AT ; (iii) the KS1 domain accepts the initiation residue from ACP1 onto a conserved cysteine, then transfers it by decarboxylative condensation onto the acyl group tethered to ACP2 ; (iv) the tethered chain is modified by KR ; (v) the ketide chain may be extended at ACP3 as discussed above ; (vi) the assembled polyketide intermediate is translocated via KS2 onto the 4-phosphopantetheine prosthetic arm of PCP1, at the start of the NRPS region.
The step to link polyketide and peptide moieties in the nascent antibiotic is of particular interest. In other ketopeptide synthetases, the first PCP is preceded by a C domain, rather than a KS domain as in XabB. The absence of an A domain upstream of PCP1 may indicate involvement of a trans-acting A domain as in HMWP1 (Gehring et al., 1998) , or transfer without chain extension as in MycA (Duitman et al., 1999) .
NRPSs typically show a modular architecture and tethered biosynthetic strategy analogous to PKSs (Cane et al., 1998 ; Keating & Walsh, 1999) . In NRPSs a C domain removes the growing peptide unit from the upstream PCP domain and couples it to the next amino acid in the chain, which has already been selected and loaded by an A domain onto the PCP in the same module Stachelhaus et al., 1998) . Other catalytic domains (e.g. epimerase or N-methyltransferase) within an elongation module can modify the newly elongated polypeptide before it is transferred to the next module in the biochemical assembly line .
The A domain in the NRPS region of XabB contains ten conserved sequences (A1-A10, Table 2 ) identified as AMP-binding, ATP-Mg# + -binding, adenine-binding or ATPase sites (Turgay et al., 1992 ; Marahiel et al., 1997) . In other NRPS systems, A domains select and load a particular amino-, hydroxy-or carboxy-acid unit . Substrate specificity is determined at the binding pocket, consisting of a stretch of about 100 amino acid residues between highly conserved motifs A4 and A5 (Conti et al., 1997) . Based on sequence analysis of known A domains, in relation to the crystal structure of the GrsA substrate-binding pocket, models have been developed to predict substrate specificity from eight or ten amino acids lining the pocket (Stachelhaus et al., 1999 ; Challis et al., 2000) . Based on alignment of complete sequences between A4 and A5 motifs, the A domain from XabB falls in a diverse cluster involved in loading of aromatic amino acids (mostly Tyr), Leu or His.
The model using eight critical residues (http :\\ jhunix.hcf.jhu.edu\" ravel\nrps\) gives no convincing prediction, because the XabB signature sequence AVKYVAND diverges from the strongly conserved residues D and V\I\L at the start and end of this eightresidue signature. Too few A domains have yet been characterized to allow reliable prediction by the model of nonproteinogenic substrates. However, an initial aspartic acid residue is highly conserved in amino-acidspecific A domains, where it is believed to electrostatically stabilize the amino group of the substrate at the binding pocket. The initial alanine residue in the case of XabB is consistent with a hydroxy-acid substrate, by analogy with the initial glycine in the signature sequence (GALHVVGI) of the hydroxyisovaleric-acid loading domain of enniatin synthetase (Haese et al., 1993) . Incorporation of a hydroxy acid would involve an ester bond in the product chain, which is consistent with the cleavage and inactivation of albicidin by the AlbD esterase (Zhang & Birch, 1997) .
Based on the architecture of the XabB NRPS region, we infer that the polyketide intermediate tethered on PCP1 is accepted by C1 and coupled to the amino-, hydroxyor carboxy-acid unit preloaded by A onto PCP2. There are no evident peptide-modifying domains (e.g. epimerase or N-methyltransferase) in the NRPS module. The final C domain at the carboxyl-terminus of XabB may transfer the intermediate product assembled by XabB to a second synthetase protein required for albicidin production as in the mycosubtilin synthetase (Duitman et al., 1999) . Alternatively, the final C domain may be involved in peptide-chain termination and cyclization, as in the enniatin, HC-toxin, rapamycin and FK506 systems (Konz & Marahiel, 1999) , which also lack a TE motif for chain termination. The ORF downstream of XabB encodes a MT involved in albicidin biosynthesis (Huang et al., 2000a) , not a functionally linked NRPS.
The full chemical structure of albicidin has not yet been determined. Albicidin is insensitive to proteases, but it is cleaved and detoxified by the AlbD esterase (Birch & Patil, 1985b ; Zhang & Birch, 1997) . Despite its relatively large size and lack of an apparent nucleoside motif in spectroscopic data, albicidin is actively accumulated in E. coli by illicit uptake through the nucleoside-specific Tsx outer-membrane pore (Birch et al., 1990 ; Fsihi et al., 1993) . Partial chemical characterization of the major antimicrobial component of the albicidin family, by methods including proton-and C"$-NMR and mass spectroscopy, indicates features including : an M r of 842 000 ; approximately 38 carbon atoms ; three or four aromatic rings ; at least one COOH group ; two OCH $ groups, including a probable O-methyl tyrosine ; a trisubstituted double bond ; and a CN linkage (Birch & (a) General structure, assuming that PCP1 acts only as a transfer point, and that a hydroxy acid is loaded by A onto PCP2, with n 1 depending on the number of extender units added at ACP2 and ACP3. (b) Stepwise construction of an alternative possible structure, assuming that acetate extender units are added at ACP2 and ACP3, an amino acid residue is added at PCP1, and tyrosine is loaded by A onto PCP2. Loading of one amino acid and one hydroxy acid in the NRPS (black) region, resulting in an amide bond and an ester bond in the product chain, is also consistent with the chemical properties of albicidin.
Patil, 1985a ; and unpublished analysis by Richard Moore at University of Hawaii and Mary Garson at University of Queensland). The molecular logic of PKS and NRPS systems has generally been interpreted in the light of known product structures. We anticipate that the biosynthetic possibilities indicated by the architecture of XabB will assist in the interpretation of chemical data to solve the structure of albicidin. It is therefore interesting to consider the likely structure of the intermediate in albicidin biosynthesis produced by XabB, based on the domain structure of this unusual synthetase (Fig. 7) . The O-methyl tyrosine component in NMR data could arise by action of the downstream XabC MT (Huang et al., 2000a) on an intermediate like the one shown in Fig.  7(b) . XabB contains five carrier protein (ACP\PCP) domains, to which the growing polyketide or polypeptide chain could be covalently tethered. Each functional ACP or PCP domain must have a specific serine side-chain phosphopantetheinylated by a dedicated phosphopantetheinyl transferase (PPTase) (Lambalot et al., 1996) . Recently, a gene (xabA) distant from xabB has been identified and found to encode a PPTase required for albicidin biosynthesis in X. albilineans (Huang et al., 2000b) . It is likely that XabB may be a target of XabA, although the ACP and\or PCP specificity of XabA to XabB remains to be experimentally determined. The characterization of XabB as a multi-modular hybrid enzyme provides new insights into the mechanism of albicidin biosynthesis and possible approaches to engineer the overproduction of albicidins. For example, the complementation experiments (Fig. 4) indicate that increased copy number of xabB stimulates early production of albicidin, but other factors become limiting during idiophase. It may be possible to increase expression of the albicidin synthetase by modifications to the promoter and TTG start codon, or to improve albicidin yields by supplying candidate substrates. The unusual enzyme organization also contributes to the emerging understanding of how microbes generate structural diversity of antibiotics, which will open possibilities for combinatorial engineering of antibiotics of mixed polyketide\peptide origin.
